Paeoniflorin alleviated muscle atrophy in cancer cachexia through inhibiting TLR4/NF-κB signaling and activating AKT/mTOR signaling

• Published in: Toxicology and applied pharmacology 2024-03, Vol.484, p.116846-116846, Article 116846
• Main Authors: Zhu, Zixia, Li, Cong, Gu, Xiaofan, Wang, Xiaoting, Zhang, Gang, Fan, Meng, Zhao, Yun, Liu, Xuan, Zhang, Xiongwen
• Format: Article
• Language: English
• Subjects: AKT/mTOR; cancer cachexia; Muscle atrophy; Paeoniflorin; TLR4/NF-κB
• ISSN: 0041-008X; 1096-0333
• DOI: 10.1016/j.taap.2024.116846

Cancer cachexia is a progressive wasting syndrome, which is mainly characterized by systemic inflammatory response, weight loss, muscle atrophy, and fat loss. Paeoniflorin (Pae) is a natural compound extracted from the dried root of Paeonia lactiflora Pallas, which is featured in anti-inflammatory, antioxidant, and immunoregulatory pharmacological activities. While, the effects of Pae on cancer cachexia had not been reported before. In the present study, the effects of Pae on muscle atrophy in cancer cachexia were observed both in vitro and in vivo using C2C12 myotube atrophy cell model and C26 tumor-bearing cancer cachexia mice model. In the in vitro study, Pae could alleviate myotubes atrophy induced by conditioned medium of C26 colon cancer cells or LLC Lewis lung cancer cells by decreasing the expression of Atrogin-1 and inhibited the decrease of MHC and MyoD. In the in vivo study, Pae ameliorated weight loss and improved the decrease in cross-sectional area of muscle fibers and the impairment of muscle function in C26 tumor-bearing mice. The inhibition of TLR4/NF-κB pathway and the activation of AKT/mTOR pathway was observed both in C2C12 myotubes and C26 tumor-bearing mice treated by Pae, which might be the main basis of its ameliorating effects on muscle atrophy. In addition, Pae could inhibit the release of IL-6 from C26 tumor cells, which might also contribute to its ameliorating effects on muscle atrophy. Overall, Pae might be a promising candidate for the therapy of cancer cachexia. [Display omitted] •Pae ameliorated muscle atrophy induced by cancer cachexia in vitro and in vivo.•Pae decreased protein degradation in muscle via TLR4/NF-κB pathway.•Pae activated protein synthesis in muscle via AKT/mTOR pathway.•Pae reduced the release of IL-6 from C26 tumor cells to alleviate myotube atrophy.